Physician

Michael Sukmin Lee, M.D.

According to 2025 Medicare claims, Michael Lee, M.D. (NPI: 1215932033) practices ophthalmology in the Portland-Vancouver-Hillsboro, OR-WA market, with the plurality of this provider's patient population coming from Clark, WA. This provider's primary affiliated billing organization is RETINA NORTHWEST P.C. (NPI: 1104813781; TIN: 930727712) and primary practice location at 98684-6951.

Lee's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 511 traditional Medicare patients, billed 27,473 HCPCS/CPT codes, and received $1,821,657 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 649 prescription claims across 167 beneficiaries totaling $33,530 in drug costs, led by Alphagan P (Brimonidine Tartrate). Open Payments data shows 28 records totaling $44,648. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,047,200 to $1,821,657. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $25,306 and ending at $33,530. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	524	8,370	$1,047,200
2016	495	8,207	$1,082,555
2017	482	7,835	$1,083,760
2018	537	8,833	$1,365,877
2019	562	9,074	$1,496,339
2020	517	8,690	$1,536,210
2021	510	8,514	$1,467,303
2022	520	8,727	$1,574,722
2023	506	17,424	$1,730,383
2024	511	27,473	$1,821,657

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	153	668	$25,306
2016	133	496	$15,286
2017	177	543	$23,133
2018	179	727	$32,374
2019	163	772	$33,303
2020	154	555	$23,024
2021	154	562	$22,636
2022	164	504	$19,166
2023	177	575	$23,325
2024	167	649	$33,530

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
67028	Injection of drug into eye	322	1,573	$108
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	189	287	$103
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	228	464	$77
J7999	Compounded drug, not otherwise classified	201	967	$72
92134	Imaging of retina	460	1,789	$34

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Alphagan P	Brimonidine Tartrate	14	995	$5,275
Prednisolone Acetate	Prednisolone Acetate	115	5,877	$5,070
Brimonidine Tartrate	Brimonidine Tartrate	33	1,855	$3,632
Loteprednol Etabonate	Loteprednol Etabonate	12	756	$3,116
Ketorolac Tromethamine	Ketorolac Tromethamine	91	2,982	$1,845

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$856	Genentech USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	22	$43,792	Bayer Healthcare Pharmaceuticals Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael Sukmin Lee, M.D.?

Tedicare shows public-source Medicare data for Michael Sukmin Lee, M.D. (NPI 1215932033), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Sukmin Lee, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael Sukmin Lee, M.D.?

Michael Sukmin Lee, M.D. is linked to RETINA NORTHWEST P.C. (billing NPI 1104813781) in the available physician profile data.

Does Michael Sukmin Lee, M.D. have Open Payments data?

Michael Sukmin Lee, M.D. has 28 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.